1. lordpenquin
2. kitcaitrn
1.kitcaitrn 06/13/2018
Surface Oncology Announces Initiation of Phase I Clinical Trial of SRF373 / NZV930
2.lordpenquin 04/19/2018
Surface Oncology Announces $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW